Pictet Asset Management (UK)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,850,803
Closed -$184M 1157
2019
Q3
$184M Sell
1,850,803
-16,873
-0.9% -$1.6M 0.39% 70
2019
Q2
$173M Sell
1,867,676
-462,837
-20% -$44M 0.37% 74
2019
Q1
$220M Sell
2,330,513
-385,692
-14% -$33.7M 0.48% 46
2018
Q4
$174K Sell
2,716,205
-43,051
-2% -$3.18M 0.44% 57
2018
Q3
$247M Sell
2,759,256
-321,256
-10% -$28.4M 0.52% 36
2018
Q2
$245M Buy
3,080,512
+90,216
+3% +$7.49M 0.59% 27
2018
Q1
$267M Buy
2,990,296
+107,708
+4% +$10.3M 0.66% 19
2017
Q4
$301M Buy
2,882,588
+363,432
+14% +$41M 0.77% 14
2017
Q3
$367M Buy
2,519,156
+110,181
+5% +$15M 1.04% 6
2017
Q2
$276M Buy
2,408,975
+143,658
+6% +$17.6M 0.85% 12
2017
Q1
$282M Buy
2,265,317
+165,159
+8% +$19.8M 0.92% 10
2016
Q4
$243M Sell
2,100,158
-21,061
-1% -$2.35M 0.9% 9
2016
Q3
$222M Buy
2,121,219
+103,410
+5% +$11.2M 0.83% 15
2016
Q2
$213M Buy
2,017,809
+1,008,034
+100% +$104M 0.83% 17
2016
Q1
$102M Buy
1,009,775
+15,199
+2% +$1.57M 0.45% 59
2015
Q4
$119M Sell
994,576
-73,424
-7% -$8.49M 0.5% 47
2015
Q3
$116M Buy
1,068,000
+34,666
+3% +$4.3M 0.51% 41
2015
Q2
$136M Buy
1,033,334
+159,306
+18% +$18.2M 0.55% 38
2015
Q1
$94.4M Buy
874,028
+127,024
+17% +$15.2M 0.39% 59
2014
Q4
$83.6M Buy
747,004
+173,670
+30% +$18.3M 0.37% 71
2014
Q3
$54.3M Sell
573,334
-26,300
-4% -$2.37M 0.26% 98
2014
Q2
$51.5M Buy
599,634
+39,300
+7% +$2.99M 0.25% 107
2014
Q1
$39.1M Sell
560,334
-29,400
-5% -$2.33M 0.2% 133
2013
Q4
$49.8M Sell
589,734
-36,600
-6% -$2.9M 0.26% 111
2013
Q3
$48.2M Sell
626,334
-49,400
-7% -$3.46M 0.27% 104
2013
Q2
$39.5M Buy
+675,734
New +$40.7M 0.23% 114

Other funds holding CELG

Pictet Asset Management (UK)'s CELG Position: Q4 2019 in Review

Pictet Asset Management (UK) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,850,803 shares — an estimated $184M sold.

Pictet Asset Management (UK) first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $367M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pictet Asset Management (UK) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 1,850,803 Celgene Corp shares in Q4 2019, an estimated $184M.
  • Pictet Asset Management (UK) first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Pictet Asset Management (UK)'s Celgene Corp position peaked at $367M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2019, filed 12 Feb 2020.